Holen Sie sich die Stockscreener-App
2.24
5.66%
0.12
Handel nachbörslich:
2.18
-0.06
-2.68%
Schlusskurs vom Vortag:
$2.12
Offen:
$2.13
24-Stunden-Volumen:
964.91K
Relative Volume:
1.11
Marktkapitalisierung:
$66.32M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-30.15M
KGV:
-0.56
EPS:
-4
Netto-Cashflow:
$-21.66M
1W Leistung:
+2.75%
1M Leistung:
-12.50%
6M Leistung:
-25.33%
1J Leistung:
-21.40%
1-Tages-Spanne:
$2.04
$2.24
1-Wochen-Bereich:
$2.04
$2.38
52-Wochen-Spanne:
$1.58
$3.84
Nrx Pharmaceuticals Inc Stock (NRXP) Company Profile
Firmenname
Nrx Pharmaceuticals Inc
Sektor
Branche
Telefon
484-254-6134
Adresse
1201 ORANGE STREET, WILMINGTON
Vergleichen Sie NRXP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NRXP
Nrx Pharmaceuticals Inc
|
2.24 | 62.76M | 0 | -30.15M | -21.66M | -4.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Nrx Pharmaceuticals Inc Stock (NRXP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-04-02 | Eingeleitet | BTIG Research | Buy |
Nrx Pharmaceuticals Inc Aktie (NRXP) Neueste Nachrichten
Movement Recap: How does NRx Pharmaceuticals Inc perform in inflationary periodsSwing Trade & Real-Time Stock Entry Alerts - baoquankhu1.vn
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Volatility Watch: How volatile is NRx Pharmaceuticals Inc Equity Warrant stockPortfolio Return Summary & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Breakout Zone: Should value investors consider Sprouts Farmers Market IncInsider Buying & Real-Time Stock Entry Alerts - baoquankhu1.vn
What is the dividend yield of NRx Pharmaceuticals Inc. Equity Warrant2025 Geopolitical Influence & Weekly High Return Stock Opportunities - mfd.ru
NRx Pharmaceuticals completes debt repayment, ends 2025 debt-free - MSN
Aug Catalysts: Is NRx Pharmaceuticals Inc Equity Warrants growth already priced inQuarterly Trade Summary & AI Optimized Trading Strategy Guides - baoquankhu1.vn
NRx Pharmaceuticals (NASDAQ: NRXP) Sets Virtual Annual Meeting for March - mychesco.com
FDA Fast Track Puts Ketamine-Based Therapy in Spotlight for Suicide Care - mychesco.com
H.C. Wainwright reiterates Buy rating on NRx Pharmaceuticals stock at $40 - Investing.com Nigeria
H.C. Wainwright reiterates Buy rating on NRx Pharmaceuticals stock at $40 By Investing.com - Investing.com India
Short Squeeze: What is the dividend yield of NRx Pharmaceuticals IncPortfolio Gains Summary & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Pullback Watch: Can GRDN withstand a market correctionTrade Ideas & Pattern Based Trade Signal System - baoquankhu1.vn
NRXP Stock: Ascendiant Capital Raises Price Target to $48 | NRXP - GuruFocus
Milestone Patient Data Eclipsing 70,000 on Real World Use - openPR.com
NRx Pharmaceuticals Addresses Nasdaq Meeting Compliance Requirements - TipRanks
NRx Pharmaceuticals Received Notice of Noncompliance - TradingView
NRx Pharmaceuticals Announces 2025 Annual Meeting Date and Record Date - citybiz
NRx Pharmaceuticals (Nasdaq:NRXP) Announces 2025 Annual Meeting Date and Record Date - The Manila Times
Sentiment Review: What are NRx Pharmaceuticals Incs recent SEC filings showingPortfolio Return Summary & AI Forecasted Entry/Exit Points - baoquankhu1.vn
NRx Pharmaceuticals Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be submitted to the FDA in Support of NRX-100 Approval - marketscreener.com
Biotech NRx Pharma outlines its business at H.C. Wainwright investor event - Stock Titan
NRx Pharmaceuticals (NASDAQ:NRXP) Given "Buy" Rating at BTIG Research - MarketBeat
NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval - Sahm
Milestone Patient Data Eclipsing 70,000 on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) - Barchart.com
FinancialContentMilestone Patient Data Eclipsing 70,000 on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) - FinancialContent
NRx Pharmaceuticals (NASDAQ: NRXP) Licenses Real-World Evidence From 70,000 Patients to Support FDA Accelerated Approval of NRX-100 - Digital Journal
NRx Pharmaceuticals Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression - citybiz
NRXP stock slips premarket as NRx says FDA fast-tracked ketamine bid with 70,000-patient dataset - TechStock²
About Us - FinancialContent
NRx Pharma Strengthens NRX-100 Approval Case With 70,000-Patient Real-World Ketamine Data - Nasdaq
Why Did NRXP Stock Surge 21% Pre-Market Today? - Stocktwits
NRx Pharmaceuticals' NRX-100 Receives FDA Fast Track Designation for Treatment of Suicidal Ideation in Depression and Bipolar Depression - Quiver Quantitative
Is NRx Pharmaceuticals Inc backed by strong institutional buying2025 Sector Review & Verified Stock Trade Ideas - baoquankhu1.vn
70,000 patients' ketamine data may help FDA weigh suicide therapy - Stock Titan
Earnings Report: Should I hold or sell NRx Pharmaceuticals Inc Equity Warrant stock in 2025Quarterly Trade Review & Daily Oversold Bounce Ideas - Bộ Nội Vụ
Retail Surge: Whats the beta of NRx Pharmaceuticals Inc stockWeekly Trade Report & Stepwise Swing Trade Plans - baoquankhu1.vn
Published on: 2026-01-11 15:15:08 - ulpravda.ru
How institutional buying supports NRx Pharmaceuticals Inc. Equity Warrant stockJuly 2025 Sentiment & High Return Trade Guides - Улправда
Why NRx Pharmaceuticals Inc. Equity Warrant stock remains a top recommendationJuly 2025 Closing Moves & Fast Exit Strategy with Risk Control - ulpravda.ru
Will NRx Pharmaceuticals Inc. Equity Warrant stock rally after Fed decisionsAnalyst Upgrade & Verified Technical Signals - ulpravda.ru
Why NRx Pharmaceuticals Inc. Equity Warrant stock appeals to dividend seekersWeekly Investment Recap & Risk Managed Investment Strategies - Улправда
Can NRx Pharmaceuticals Inc. stock withstand economic slowdownWeekly Market Report & Technical Entry and Exit Alerts - ulpravda.ru
Will NRx Pharmaceuticals Inc. Equity Warrant stock outperform value stocksWeekly Earnings Recap & Consistent Profit Trading Strategies - ulpravda.ru
Market Recap: Is NRx Pharmaceuticals Inc. Equity Warrant stock in correction or buying zoneJuly 2025 Earnings & Safe Capital Allocation Plans - ulpravda.ru
PRN_FinancialWrapper | PR NewswireNRX Pharmaceuticals, Inc.Warrant (Nasdaq:NRXPW) Stock Quote - FinancialContent
Can NRx Pharmaceuticals Inc. stock beat market expectations this quarterWeekly Risk Report & Daily Chart Pattern Signal Reports - ulpravda.ru
NRX Pharmaceuticals, Inc.Common Stock (NQ: NRXP - FinancialContent
Why NRx Pharmaceuticals Inc. Equity Warrant stock attracts global investorsLow Beta Stocks & Start Your Free Trading Journey Today - ulpravda.ru
NRXP SEC FilingsNrx Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
A High-Stakes Alliance Aims to Standardize Mental Health Care at Scale - MyChesCo
Finanzdaten der Nrx Pharmaceuticals Inc-Aktie (NRXP)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.09%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):